Inventaire - dina vänner och gemenskaper är ditt bästa bibliotek

Quantification of HER2 heterogeneity in breast cancer-implications for identification of sub-dominant clones for personalised treatment

författare

Darragh G. McArt

Niamh E Buckley

publicerad i: Scientific Reports

utgivningsår: 2016-03-21

språk: engelska

huvudämne: heterogen

Refererar artiklar 18

Datum

Titel

Författare

2015-07-02

Tumorigenesis: it takes a village

Kornelia Polyak
2015-03-03

Intratumoral heterogeneity in a Trp53-null mouse model of human breast cancer

Charles M. Perou, Anna Tsimelzon
2014-07-30

Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity

Kornelia Polyak, Franziska Michor
2014-04-01

Tumour cell heterogeneity maintained by cooperating subclones in Wnt-driven mammary cancers
2014-04-16

The prognostic significance of the aberrant extremes of p53 immunophenotypes in breast cancer

Darragh G. McArt, Charlotte S Wilhelm-Benartzi
2013-08-04

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

Eric Winer
2012-12-04

Reliability of core needle biopsy for determining ER and HER2 status in breast cancer

Judith R Kroep
2012-07-16

Evaluating tumor heterogeneity in immunohistochemistry-stained breast cancer tissue.
2012-03-02

Intratumoral heterogeneity of HER2 gene amplification in breast cancer: its clinicopathological significance
2012-09-01

Analysis of the concordance rates between core needle biopsy and surgical excision in patients with breast cancer
2011-02-01

A functional role for tumor cell heterogeneity in a mouse model of small cell lung cancer
2011-08-01

Heterogeneous HER2 gene amplification: impact on patient outcome and a clinically relevant definition.

Caroline Seynaeve
2011-06-20

HER2 testing in the UK: recommendations for breast and gastric in-situ hybridisation methods

Ian Ellis, Sarah E. Pinder, Merdol Ibrahim
2010-04-19

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

Antonio C. Wolff, Patrick L. Fitzgibbons, Anthony Rhodes, Fred Sweep, Daniel W Visscher
2009-04-13

Disease-free survival according to degree of HER2 amplification for patients treated with adjuvant chemotherapy with or without 1 year of trastuzumab: the HERA Trial

Martine Piccart-Gebhart, Evandro de Azambuja, Mitch Dowsett, Giuseppe Viale
2009-04-01

Genetic heterogeneity in HER2 testing in breast cancer: panel summary and guidelines

Gail H. Vance
2008-03-01

Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype

Maggie Chon U Cheang, Charles M. Perou
1987-01-09

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

Artikel - wd:Q36707771

Välkommen till Inventaire

din gemenskap och vänners bibliotek

lär mer